Archives

by in
Entry Author Date Location
Genocea Biosciences Secures $30,000,000 Series C Financing 10/10/12 Boston
Transphorm Garners $35,000,000 Series E Round 10/02/12 San Diego
Kymeta Receives $12,000,000 New Financing Round 08/22/12 Seattle
Siluria Attracts Paul Allen, Gets $30M to Turn Natural Gas Into Chemicals, Fuels 07/26/12 San Francisco
Siluria Technologies Lands $30,000,000 Series C Funding Round 07/26/12 San Francisco
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
Shapeways Receives $6,200,000 New Financing Round 06/19/12 New York
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Kala Pharmaceuticals Lands $6,200,000 Seed Round 03/14/12 Boston
With $21.7M in New Funding, Luxtera Signs Deal to Make Optical Chip 03/01/12 San Diego
Luxtera Garners $21,700,000 Series C Funding Round 02/27/12 San Diego
Learn to Learn, and Embrace Serendipity 01/18/12 San Diego
IBM Gets Emptoris, Nuance Buys Vlingo, & More Boston-Area Deals News 12/21/11 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Siluria Pockets $20M For Making Cleaner Plastics, Fuels 09/27/11 San Francisco
Siluria Technologies Lands $20,000,000 Series B Funding 09/27/11 San Francisco
Transphorm Garners $24,999,999 New Funding Round 06/16/11 San Diego
Five Questions on Innovation, Health IT, and Biotech for Lux Capital’s New Venture Partner Richard Foster 05/02/11 New York
Lux Capital Adds James Woolsey and Richard Foster 04/26/11 New York
Trend Spotting: The Top 9 Rise & Falls We See in the Year Ahead 01/11/11 San Diego
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business 01/03/11 Boston
Genocea Biosciences Obtains $35,000,000 Series B Funding Round 01/03/11 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News 11/18/10 Boston
Cerulean Grabs $24M for Nano Drugs 11/15/10 Boston
Cerulean Pharmaceuticals Receives $24,000,000 Series C Funding Round 11/15/10 Boston
$3M for Kala Pharmaceuticals 11/12/10 Boston
Page 2 of 3 « previous page · next page »